Bio-Matrix Announces Evaluation of CAD/CAM Designs

Bio-Matrix Scientific Group announced that it is evaluating its CAD/CAM designs for stem cell and tissue management instrumentation. The company anticipates submitting a 510(k) filing for its stem cell and tissue management instruments toward the end of May 2005.

Reuters (http://today.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?view=PR&symbol=BMXG.PK&storyID=62442%2B29-Mar-2005%2BBW)